Platelet-derived integrin- and tetraspanin-enriched tethers exacerbate severe inflammation.
Saved in:
| Title: | Platelet-derived integrin- and tetraspanin-enriched tethers exacerbate severe inflammation. |
|---|---|
| Authors: | Kusch, Charly (AUTHOR), Stegner, David (AUTHOR), Weiss, Lukas J. (AUTHOR), Nurden, Paquita (AUTHOR), Burkard, Philipp (AUTHOR), Johnson, Denise (AUTHOR), Bergmeier, Wolfgang (AUTHOR), Onursal, Ceylan (AUTHOR), Navarro, Stefano (AUTHOR), Hackenbroch, Christian (AUTHOR), Pfeiffer, Dennis (AUTHOR), Bonfiglio, Sabrina Ivana (AUTHOR), Meub, Mara (AUTHOR), Gross, Carina (AUTHOR), Schenk, Joachim (AUTHOR), Fumagalli, Valeria (AUTHOR), Mott, Kristina (AUTHOR), Bender, Markus (AUTHOR), Iannacone, Matteo (AUTHOR), Andres, Oliver (AUTHOR) |
| Source: | Science. 1/22/2026, Vol. 391 Issue 6783, p1-16. 16p. |
| Subjects: | Inflammation, Sepsis, Integrins, Blood platelets, COVID-19, Tetraspanin |
| Abstract: | Platelet integrin αIIbβ3 is essential for hemostasis, thrombosis, and inflammation. We found that ligation of αIIbβ3 by von Willebrand factor or fibrin under flow triggered its accumulation in plasma membrane extensions or "platelet-derived integrin- and tetraspanin-enriched tethers" (PITTs). PITTs remained anchored to leukocytes or endothelial cells, whereas the partially αIIbβ3-deficient platelet body detached. Although still responsive to stimuli, αIIbβ3-deficient platelets did not support thrombus formation. PITTs promoted leukocyte activation and vascular inflammation in mouse models of infection and endotoxemia, and αIIbβ3 blockade reduced immune-mediated tissue damage. In patients with sepsis, COVID-19, or severe infections, PITT formation and platelet αIIbβ3 loss correlated with disease severity and adverse outcomes. We propose that PITTs are proinflammatory structures that amplify immune responses while contributing to platelet dysfunction in thrombo-inflammatory disease. Editor's summary: Altered platelet function has been proposed to contribute to the dysregulated blood clotting and inflammation that occur during extreme immune responses. Kusch et al. observed that platelets from patients with severe COVID infection or sepsis had a distinctive morphology, with long membrane extensions that were enriched in an adhesion molecule, the integrin αIIbβ3 (see the Perspective by Perrella and Rayes). In vitro, murine platelets formed these structures, described as platelet-derived integrin and tetraspanin-enriched tethers (PITTs), under flow when αIIbβ3 was triggered. In mouse models of lung inflammation, PITTs separated from the platelet body and remained attached to endothelial cells and neutrophils, stimulating inflammation. Detachment of PITTs left platelets depleted of αIIbβ3 and impaired in their ability to promote blood clots. In humans, platelets with indicators of PITT formation were correlated with worse disease severity. —Sarah H. Ross INTRODUCTION: Integrins are a family of heterodimeric transmembrane receptors that link the extracellular matrix to the cytoskeleton and regulate adhesion, migration, and signaling in many cell types. The platelet integrin αIIbβ3 (also designated GPIIb/IIIa) is among the best-studied integrins and is indispensable for hemostasis and thrombosis. Beyond their established role in clotting, platelets contribute to immune-mediated tissue damage in inflammatory and infectious disease. RATIONALE: Because the platelet effector mechanisms that mediate thrombo-inflammation were unclear, we sought to understand the role of αIIbβ3 and how its engagement contributes to altered platelet function. RESULTS: In blood smears and tissue samples from patients with severe COVID-19, sepsis, or bacterial infection, we observed alterations in platelet morphology and integrin expression. Specifically, we noted the presence of elongated platelet-derived membrane tethers that stained strongly for αIIbβ3 and its associated tetraspanin CD9. We called these structures platelet-derived integrin- and tetraspanin-enriched tethers (PITTs). Indicators of an increased abundance of PITT formation correlated with reduced αIIbβ3/CD9 surface levels in circulating platelets. Flow cytometry confirmed selective loss of these receptors, whereas other major glycoproteins were preserved. Using human and murine platelets, we demonstrated that ligation of αIIbβ3 by von Willebrand factor or fibrin under flow was sufficient to trigger rapid integrin clustering and tether formation, independent of classical platelet activation. PITTs remained attached to leukocytes or endothelium, whereas the platelet body detached, partially depleted of αIIbβ3/CD9. We generated Itga2b-GFP (green fluorescent protein) knock-in mice and performed live imaging of PITT formation in vitro and confirmed αIIbβ3/CD9 enrichment in PITTs and their detachment from platelet bodies and deposition in inflamed lungs during endotoxemia, bacterial pneumonia, or SARS-CoV-2 infection using in vivo mouse studies. PITTs formed without detectable platelet degranulation, phosphatidylserine exposure, or integrin activation, distinguishing them from classical extracellular vesicles or activation-induced protrusions. In vivo, PITTs decorated neutrophils, inducing calcium fluxes and up-regulation of activation markers, suggesting that PITTs could promote inflammatory signaling. In models of acute lung injury, genetic deletion of von Willebrand factor or pharmacologic blockade of αIIbβ3 decreased PITT formation, neutrophil infiltration, and tissue damage. In patients with sepsis, reduced platelet CD41a expression—reflecting PITT release—correlated with higher sequential organ failure assessment (SOFA) scores, acute respiratory distress syndrome, and mortality. Stratification by CD41a levels revealed that patients in the lowest quartile had substantially increased odds for adverse outcomes. CONCLUSION: We propose that PITTs act as platelet-derived structures that redistribute the αIIbβ3/CD9 pool during severe infection and inflammation. By anchoring to leukocytes and endothelial cells, PITTs may amplify vascular inflammation and immune activation while leaving behind platelets with impaired adhesive function. This mechanism may explain the paradoxical coexistence of thrombo-inflammation and bleeding in critical illness. Beyond hemostasis, αIIbβ3 may serve as a proinflammatory effector that shapes immune responses and clinical outcome in inflammatory and infectious disease. Targeting PITT formation may offer new opportunities to modulate thrombo-inflammation without impairing platelet viability. Nonactivated platelets release integrin- and tetraspanin-enriched tethers to promote thrombo-inflammation.: Circulating platelets can use their principal adhesion receptor, integrin αIIbβ3, to switch between hemostatic and thrombo-inflammatory programs. At sites of vascular injury, classical activation triggers inside-out signaling of αIIbβ3, promoting fibrinogen binding, platelet adhesion, and thrombus formation. Under thrombo-inflammatory conditions, nonactivated platelets generate PITTs that can attach to leukocytes and endothelial cells, exacerbating inflammation, whereas the platelet body detaches in a state partially depleted of αIIbβ3. Rest., resting; act., activated. [Figure created with BioRender.com] [ABSTRACT FROM AUTHOR] |
| Copyright of Science is the property of American Association for the Advancement of Science and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Platelet integrin αIIbβ3 is essential for hemostasis, thrombosis, and inflammation. We found that ligation of αIIbβ3 by von Willebrand factor or fibrin under flow triggered its accumulation in plasma membrane extensions or "platelet-derived integrin- and tetraspanin-enriched tethers" (PITTs). PITTs remained anchored to leukocytes or endothelial cells, whereas the partially αIIbβ3-deficient platelet body detached. Although still responsive to stimuli, αIIbβ3-deficient platelets did not support thrombus formation. PITTs promoted leukocyte activation and vascular inflammation in mouse models of infection and endotoxemia, and αIIbβ3 blockade reduced immune-mediated tissue damage. In patients with sepsis, COVID-19, or severe infections, PITT formation and platelet αIIbβ3 loss correlated with disease severity and adverse outcomes. We propose that PITTs are proinflammatory structures that amplify immune responses while contributing to platelet dysfunction in thrombo-inflammatory disease. Editor's summary: Altered platelet function has been proposed to contribute to the dysregulated blood clotting and inflammation that occur during extreme immune responses. Kusch et al. observed that platelets from patients with severe COVID infection or sepsis had a distinctive morphology, with long membrane extensions that were enriched in an adhesion molecule, the integrin αIIbβ3 (see the Perspective by Perrella and Rayes). In vitro, murine platelets formed these structures, described as platelet-derived integrin and tetraspanin-enriched tethers (PITTs), under flow when αIIbβ3 was triggered. In mouse models of lung inflammation, PITTs separated from the platelet body and remained attached to endothelial cells and neutrophils, stimulating inflammation. Detachment of PITTs left platelets depleted of αIIbβ3 and impaired in their ability to promote blood clots. In humans, platelets with indicators of PITT formation were correlated with worse disease severity. —Sarah H. Ross INTRODUCTION: Integrins are a family of heterodimeric transmembrane receptors that link the extracellular matrix to the cytoskeleton and regulate adhesion, migration, and signaling in many cell types. The platelet integrin αIIbβ3 (also designated GPIIb/IIIa) is among the best-studied integrins and is indispensable for hemostasis and thrombosis. Beyond their established role in clotting, platelets contribute to immune-mediated tissue damage in inflammatory and infectious disease. RATIONALE: Because the platelet effector mechanisms that mediate thrombo-inflammation were unclear, we sought to understand the role of αIIbβ3 and how its engagement contributes to altered platelet function. RESULTS: In blood smears and tissue samples from patients with severe COVID-19, sepsis, or bacterial infection, we observed alterations in platelet morphology and integrin expression. Specifically, we noted the presence of elongated platelet-derived membrane tethers that stained strongly for αIIbβ3 and its associated tetraspanin CD9. We called these structures platelet-derived integrin- and tetraspanin-enriched tethers (PITTs). Indicators of an increased abundance of PITT formation correlated with reduced αIIbβ3/CD9 surface levels in circulating platelets. Flow cytometry confirmed selective loss of these receptors, whereas other major glycoproteins were preserved. Using human and murine platelets, we demonstrated that ligation of αIIbβ3 by von Willebrand factor or fibrin under flow was sufficient to trigger rapid integrin clustering and tether formation, independent of classical platelet activation. PITTs remained attached to leukocytes or endothelium, whereas the platelet body detached, partially depleted of αIIbβ3/CD9. We generated Itga2b-GFP (green fluorescent protein) knock-in mice and performed live imaging of PITT formation in vitro and confirmed αIIbβ3/CD9 enrichment in PITTs and their detachment from platelet bodies and deposition in inflamed lungs during endotoxemia, bacterial pneumonia, or SARS-CoV-2 infection using in vivo mouse studies. PITTs formed without detectable platelet degranulation, phosphatidylserine exposure, or integrin activation, distinguishing them from classical extracellular vesicles or activation-induced protrusions. In vivo, PITTs decorated neutrophils, inducing calcium fluxes and up-regulation of activation markers, suggesting that PITTs could promote inflammatory signaling. In models of acute lung injury, genetic deletion of von Willebrand factor or pharmacologic blockade of αIIbβ3 decreased PITT formation, neutrophil infiltration, and tissue damage. In patients with sepsis, reduced platelet CD41a expression—reflecting PITT release—correlated with higher sequential organ failure assessment (SOFA) scores, acute respiratory distress syndrome, and mortality. Stratification by CD41a levels revealed that patients in the lowest quartile had substantially increased odds for adverse outcomes. CONCLUSION: We propose that PITTs act as platelet-derived structures that redistribute the αIIbβ3/CD9 pool during severe infection and inflammation. By anchoring to leukocytes and endothelial cells, PITTs may amplify vascular inflammation and immune activation while leaving behind platelets with impaired adhesive function. This mechanism may explain the paradoxical coexistence of thrombo-inflammation and bleeding in critical illness. Beyond hemostasis, αIIbβ3 may serve as a proinflammatory effector that shapes immune responses and clinical outcome in inflammatory and infectious disease. Targeting PITT formation may offer new opportunities to modulate thrombo-inflammation without impairing platelet viability. Nonactivated platelets release integrin- and tetraspanin-enriched tethers to promote thrombo-inflammation.: Circulating platelets can use their principal adhesion receptor, integrin αIIbβ3, to switch between hemostatic and thrombo-inflammatory programs. At sites of vascular injury, classical activation triggers inside-out signaling of αIIbβ3, promoting fibrinogen binding, platelet adhesion, and thrombus formation. Under thrombo-inflammatory conditions, nonactivated platelets generate PITTs that can attach to leukocytes and endothelial cells, exacerbating inflammation, whereas the platelet body detaches in a state partially depleted of αIIbβ3. Rest., resting; act., activated. [Figure created with BioRender.com] [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 00368075 |
| DOI: | 10.1126/science.adu2825 |
